SouthState’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56K Hold
11
– – ﹤0.01% 1030
2026
Q2
$1.85K Hold
11
– – ﹤0.01% 966
2026
Q1
$1.45K Hold
11
– – ﹤0.01% 974
2025
Q4
$1.56K Hold
11
– – ﹤0.01% 1038
2025
Q3
$1.54K Hold
11
– – ﹤0.01% 982
2025
Q2
$1.38K Sell
11
-24
-69% -$2.75K ﹤0.01% 1187
2025
Q1
$3.87K Buy
+35
New +$4.43K ﹤0.01% 1039

Other funds holding NBIX

SouthState's NBIX Position: Q3 2026 in Review

SouthState held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 11 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

SouthState first reported a position in NBIX in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.87K in Q1 2025. 630 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • SouthState held 11 shares of Neurocrine Biosciences worth $1.56K as of Q3 2026.
  • SouthState left its Neurocrine Biosciences share count unchanged in Q3 2026.
  • Neurocrine Biosciences made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1030 holding.
  • SouthState first reported a position in Neurocrine Biosciences in Q1 2025 and has held it in 7 quarters since.
  • SouthState's Neurocrine Biosciences position peaked at $3.87K in Q1 2025.
  • 630 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.